A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

Low to moderate vitamin D doses may reduce MS relapse rates, while high doses show no additional benefit, according to a new ...

Columnist Ben Hofmeister says the pre-flight safety rules that require you to put your oxygen mask on first also apply to ...

As columnist Ahna Crum marveled at the feats of Olympic medalists, she decided to grab a pair of ice skates and test her own ...

A second clinical trial testing fenebrutinib for MS has met its main goal, once again beating approved Aubagio in reducing ...

Long-term exposure to air pollution may increase MS risk, while short-term exposure may worsen disease activity and ...

Even as guest writer Brian Howard's multiple sclerosis has progressed, he's still living a life full of travel, adventure, ...

Columnist Desiree Lama writes about the grief that dwells beneath the surface of MS, and how it reshapes the lives of those ...

Foralumab reduced microglial activity in people with nonactive SPMS, and this was linked to reductions in proinflammatory ...

A test measuring proteins in spinal fluid may help support the diagnosis of MS, especially in patients whose disease is ...

Donald Kushner says living with MS has made him the gravitational center of his family, and the person in the middle in group ...

Ocrevus (ocrelizumab) and Tysabri (natalizumab) appear equally effective at controlling relapses and MS progression, a study ...